SFM — Sprouts Farmers Market

Sprouts Farmers Market just reported its best year on record — $8.8 billion in revenue, 7.3% comparable store sales growth, 38.8% gross margins, $5.31 in earnings per share — and the stock trades at less than fifteen times those earnings after a 58% decline from its June 2025 peak. The apparent contradiction is explained by the FY2026 guidance: management directed investors to expect comparable store sales between negative one and positive one percent, acknowledging a sharp deceleration in the back half of fiscal 2025. The market concluded that the two exceptional comp years of 2024 and 2025 were borrowed time, repriced accordingly, and left behind a debt-free business with 38.8% gross margins trading at roughly ten times normalized pre-tax earnings with a clear path to doubling its store count. At $75.65, that repricing has overshot.

---

When a high-quality business falls 58% in six months, the analytical task is not to explain why the stock went down — explanations are always available — but to determine whether the permanent earnings power of the business has changed in proportion to the stock price. In most cases of this magnitude, the answer is no. A stock that was priced at twenty-two times earnings during a period of exceptional performance and subsequently priced at fourteen times earnings during a guidance reset has not necessarily declined in proportion to any permanent change in the business. The question is whether the business that earned $5.31 per share in 2025 is structurally capable of earning materially more than that over the next decade, and whether the current price is a reasonable entry point for that trajectory. For Sprouts, the answer to both questions is yes.

The natural and organic food retail sector has undergone a structural shift that the conventional grocery industry has not been able to absorb. U.S. certified organic product sales reached $76.6 billion in 2025, growing at 6.8% year-over-year — twice the growth rate of the broader food market. The penetration of organic products into overall food spending is still only approximately 6%, implying that the secular growth story is in early innings relative to the addressable base. The structural forces driving the shift are not marketing trends; they are the combination of an aging and more health-conscious consumer base, the GLP-1 drug cohort (Ozempic and Wegovy users who eat less but prioritize nutritional density over volume), accelerating awareness of ingredient quality (the no-seed-oil and gut-health movements that have structurally favored Sprouts' assortment), and a generation of younger consumers who distrust processed food in ways their parents did not. These forces do not reverse when interest rates move or when a CEO guides to a challenging quarter.

The competitive structure of the natural and organic food retail market rewards differentiation rather than scale. The dominant players in conventional grocery — Kroger, Walmart, Albertsons — have attempted to expand their natural and organic sections, and have achieved meaningful penetration. But the constraints of their business model prevent replication of a truly differentiated format: their fixed-cost structure demands that they carry national branded products that generate slotting fees and promotional income, which crowds out the emerging brands and small-producer relationships that define a discovery-oriented specialty format. Trader Joe's has built an extraordinary business on private label exclusivity, but its format requires that customers trust the store's judgment entirely, which limits the addressable audience to those who are already committed to a specific brand of simplicity. Whole Foods competes on premium quality and Amazon ecosystem integration, but its 40,000 to 45,000 square foot stores and premium pricing create a different value proposition than Sprouts. The gap between those three models — conventional, private-label discovery, and premium specialty — is the space Sprouts occupies, and it is not a small space.

Sprouts describes itself as a produce-centric specialty grocer targeting the "health enthusiast" consumer — a segment it estimates at roughly 15% of the U.S. population, or approximately $290 billion of the $1.6 trillion food-at-home market. The stores are 23,000 to 25,000 square feet — roughly half the footprint of a conventional supermarket — and structured around a large center produce department that creates the physical sensation of a farmers market rather than a grocery warehouse. Approximately 70% of the assortment is differentiated, meaning it cannot be found at a Kroger or a Walmart. The company employs a dedicated "forager" team that identifies emerging brands and products, onboarding 30 to 40 new brands per month and introducing over 7,000 new items in FY2025 alone. Organic products represent more than 30% of total sales. The 600 Sprouts-branded private label items represent approximately 24% to 25% of total revenue, generating higher margins than branded goods and creating exclusivity within the specialty segment. Self-distribution is advancing — 75% of stores are now served through company-owned distribution centers for fresh meat, with the Northern California facility on track for completion in Q2 2026 — improving both freshness and gross margins as the rollout completes.

The proof that this differentiated format produces a genuine competitive advantage is not qualitative; it is in the gross margin comparison. Sprouts earned a 38.8% gross margin in FY2025. Kroger, the largest conventional supermarket chain in the United States, earned a 23.1% gross margin. Walmart's grocery-inclusive gross margin was approximately 24.6%. This differential cannot be explained by accounting differences alone — it reflects the structural reality that Sprouts' assortment, customer, and format command a premium that is absent from conventional grocery, and that premium has been expanding rather than contracting:

Retailer	Gross Margin	Operating Margin	Format
Sprouts Farmers Market	38.8%	7.8%	Natural/Organic Specialty
Kroger	~23.1%	~1.5–2%	Conventional Supermarket
Walmart (overall)	~24.6%	~4–5%	Discount General Merchandise
Target (overall)	~30%	~5.3%	General Merchandise/Food

A 38.8% gross margin in food retail is not incidental to the format — it is the format. The Sprouts customer is purchasing products they cannot find at Kroger, at a price point below Whole Foods, in an environment designed for discovery rather than efficiency. The pricing power that generates a 15-point gross margin premium over conventional grocery is not at risk from Kroger's expanding organic section because Kroger's model cannot accommodate the curation, the supplier relationships, or the store environment that command the premium. The gross margin has expanded 240 basis points over five years, from 36.4% in FY2021 to 38.8% in FY2025. That is a moat that is strengthening, not eroding.

Full-year 2025 financials reflect the best operating performance in the company's history. Net sales of $8.81 billion grew 14.1% year-over-year. Comparable store sales of 7.3% included a Q1 2025 result of 11.7% — one of the strongest single-quarter comp performances in the company's history — followed by Q2 at approximately 10.4%, Q3 at 5.9%, and Q4 at 1.6%. The deceleration from Q1 through Q4 is what triggered the guidance reset and the stock decline. EBIT was approximately $675 to $680 million at a 7.8% operating margin. Diluted EPS of $5.31 represented a 42% increase from FY2024's $3.75. Cash from operations was $716 million. Free cash flow, after $224 million in capital expenditures net of landlord reimbursements, was approximately $492 million. The company ended the year with $257 million in cash and approximately $53 million in long-term financial debt — essentially debt-free, which is a near-singular achievement among specialty retailers of this scale.

The FY2026 guidance is the discordant note, and it deserves honest examination. Management guided comparable store sales to between negative one and positive one percent on a full-year basis, with Q1 2026 expected at between negative three and negative one percent as the company laps Q1 2025's exceptional 11.7% result. EBIT is guided to $675 to $695 million — essentially flat against FY2025's $675 to $680 million — meaning that the earnings contribution of 40+ new store openings is being fully absorbed by the comp deceleration. Diluted EPS guidance of $5.28 to $5.44 is flat to slightly above FY2025's $5.31. CEO Jack Sinclair stated that the company was "not happy with how FY2025 finished" and cited softening transaction counts and increased consumer focus on affordability. The loyalty program, launched in late 2024, had reached approximately 15% customer penetration by year-end 2025 — below management's hopes for the pace of enrollment.

What drove Q1 2025's 11.7% comp? The honest answer involves a combination of factors that do not fully repeat: the quarter benefited from above-trend consumer engagement with premium natural food that had been building since mid-2024, easy prior-year comparisons, and operational improvements in-store that created a period of unusually strong organic volume. By Q4 2025, as these tailwinds faded and the consumer became more cautious about grocery spending, the comp fell to 1.6%. The question is whether the underlying structural demand for the Sprouts format — the health enthusiast consumer, the organic category growth, the discovery-oriented format — supports a 3% to 4% long-run comp, or whether the 2024 and 2025 exceptional performance was borrowed from a lower-growth future. The evidence from the gross margin trajectory — expanding steadily for five years — suggests a business with genuine pricing power and deepening differentiation, not one that borrowed from the future.

Jack Sinclair has led Sprouts since 2019, bringing three decades of grocery operational experience including the EVP of U.S. Grocery at Walmart and leadership roles at Safeway in the U.K. The strategic transformation he has executed — tighter differentiation, smaller format, self-distribution buildout, and disciplined organic expansion — is visible in the five-year financial record. The capital allocation record is equally clear: since the IPO in 2013, the company has returned approximately $958 million to shareholders through repurchases, reducing the share count materially. The FY2026 plan includes at least $300 million in additional repurchases against a $836 million remaining authorization. At $75.65 per share, a $300 million buyback retires approximately 3.97 million shares — a 4.1% annual reduction in share count that accretes per-share value regardless of whether comparable store sales recover. The combination of new store earnings contribution and share count reduction means that EPS grows in the mid-to-high single digits annually even if comparable store sales remain flat for several years. This is not a company that requires exceptional comp performance to compound shareholder value. It requires operational execution and disciplined capital allocation — both of which the track record supports.

The growth runway table shows five years of the core metrics that determine whether the thesis is intact or broken:

Year	Stores	Comp Sales	Gross Margin	EBIT Margin	Diluted EPS
FY2021	374	+5.6%	36.4%	5.2%	$1.46
FY2022	391	+4.9%	36.7%	5.7%	$1.95
FY2023	407	+3.7%	37.5%	6.5%	$2.50
FY2024	440	+7.6%	38.1%	7.1%	$3.75
FY2025	477	+7.3%	38.8%	7.8%	$5.31
FY2026E	~517	-1% to +1%	~38%	~7.3%	$5.28–5.44

The five-year trend lines tell two stories simultaneously. The first is the unambiguous structural improvement: gross margin has expanded from 36.4% to 38.8%, EBIT margin from 5.2% to 7.8%, EPS from $1.46 to $5.31, store count from 374 to 477. Every year from FY2021 through FY2025 produced higher margins and higher earnings than the prior year. The format is not stagnating — it is improving operationally as scale enables better supplier terms, self-distribution reduces spoilage and improves freshness, and private label reaches a higher proportion of total revenue. The second story is the FY2026 guidance: a single line at the bottom that shows comp deceleration, margin plateau, and flat EPS. The investor must answer which story is more predictive of the next five years: the trend of structural improvement, or the single-year inflection downward. The trend's credentials are five years of compounding evidence.

As of FY2025, Sprouts operates 477 stores in 24 states. Management has stated a long-term target of 1,000 to 1,200 locations, with some references to a potential of up to 1,400 stores. Against the conservative 1,000-store goal, Sprouts has captured approximately 47.7% of its targeted footprint — 523 or more stores remain to be opened in markets where management believes the format will work. The company has over 140 approved locations in its pipeline and 95 executed leases, providing three-plus years of near-term visibility into the expansion cadence. Geographic white space is substantial: Sprouts has no presence in Massachusetts, minimal presence in New York (its first New York store opened in Centereach, Long Island in January 2026), and has not yet entered the full Midwest corridor. The unit economics of new stores have outperformed management's internal expectations for two consecutive years, which means the expansion is not a growth-at-any-cost program but a disciplined deployment of capital into a proven format. At approximately $6 to $8 million in net capital per new store opening (after landlord allowances), the economics are favorable and the returns exceed the cost of capital.

The most credible bear argument against the "compelling" conclusion is that the Northeast expansion — the most obvious remaining white space — is economically different from the Sun Belt markets that built the company's track record. Sprouts' power base is in Texas, Arizona, California, Colorado, and Florida, where real estate is cheaper, labor markets are more flexible, and the health enthusiast demographic is embedded in the regional culture. New York, Massachusetts, and New Jersey present higher rents, more union-friendly labor environments, stronger incumbents (Trader Joe's density in Manhattan and Boston is extraordinary), and lower existing brand awareness. A company that earns excellent returns on capital in Phoenix may earn mediocre returns on capital in Brooklyn. This argument deserves weight. The answer is that the Northeast is not the near-term expansion driver — the company is first penetrating the Midwest, adding stores in existing markets where distribution density is already established, and testing the New York market with single-store caution. The long-run 1,000-store target does not require the Northeast to succeed at Sun Belt economics. It requires it to succeed at adequate economics. One store on Long Island does not resolve this question, but the expansion pace and order of operations is disciplined.

At $75.65 per share, the market capitalization is approximately $7.4 billion. With $257 million in cash, $53 million in financial debt, and approximately $1.9 billion in operating lease liabilities included in the enterprise value calculation, the enterprise value is approximately $8.8 billion. Against FY2025 revenue of $8.81 billion, that is essentially 1.0 times sales — a multiple that reflects virtually no premium for the quality of the business relative to the commodity businesses this revenue would imply if it were conventional grocery. Against FY2026E EBIT of $685 million (midpoint), the enterprise value multiple is approximately 12.8 times operating income. The pre-tax earnings yield on normalized FY2026 guidance at $75.65 per share is approximately 9.6% — four percentage points above the current inflation rate and generating a real after-tax return of approximately four to four-and-a-half percent per year at the current earnings level alone, before any growth.

The intelligent bear says: the comp deceleration is structural, not cyclical — the health enthusiast niche is either saturating or being encroached on by Amazon/Whole Foods pricing improvements and Trader Joe's expanding assortment, and the stock deserves to trade at twelve times earnings, not eighteen. At twelve times FY2026E EPS of $5.36, the stock is worth approximately $64, implying modest additional downside from current levels. This argument fails on the gross margin evidence. If Whole Foods were encroaching on Sprouts' value proposition, or if Trader Joe's were pulling Sprouts' core customer away, the first visible sign would be gross margin compression — either through weaker pricing power or increased promotional activity. Sprouts' gross margin has expanded every year for five consecutive years, including FY2025, and is guided roughly flat in FY2026. A business whose competitive position is eroding does not expand gross margins for five years. The comp deceleration is a volume story, not a pricing story — and the volume story is partly a lapping issue against exceptional prior comparisons, and partly a macro environment in which all grocery traffic is under pressure from high cumulative food inflation.

For the thesis to weaken materially, Sprouts would need to demonstrate either sustained negative comparable store sales in markets outside the difficult Northeast entry points, or meaningful gross margin erosion toward conventional grocery levels. Neither has occurred. The FY2026 guidance of flat-to-negative comps is a challenge, but it is a volume challenge in a specific macro environment against specific year-ago comparisons — not a structural deterioration of the pricing premium that is the company's most important competitive asset. A format that earns 38.8% gross margins against a 23% industry benchmark does not lose its structural advantage in one guidance reset.

At roughly ten times normalized pre-tax earnings, with zero net debt, a balance sheet generating nearly $500 million in annual free cash flow, a management team returning $300 million per year to shareholders, and a store count that is 477 of a targeted 1,000-plus — the price assumes permanence of both the comp deceleration and the multiple compression. Both assumptions are probably wrong. The comp deceleration is almost certainly cyclical, anchored to a difficult comparison period and a broadly cautious consumer environment. The multiple compression reflects market disappointment at a single guidance reset in an otherwise improving business.

The business earned $5.31 last year on 477 stores. At 1,000 stores, after a decade of operating leverage and buybacks, it will earn considerably more than that. Fourteen times earnings is not the price you pay for a business on that trajectory.

All financial data reflects publicly available information through March 2026. This analysis is not investment advice.